CAS: 199475-39-3 - 1-(3-Pyrrolidinoproyl)homopiperazine
Formula:C12H25N3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 1H-1,4-Diazepine, hexahydro-1-[3-(1-pyrrolidinyl)propyl]- REF: IN-DA002C4QCAS: 199475-39-3 | - - - | To inquire | Fri 07 Feb 25 |
 | 1-[3-(Pyrrolidin-1-yl)prop-1-yl]homopiperazine REF: 54-OR3475CAS: 199475-39-3 | 97% | 54.00 € | Fri 14 Feb 25 |
 | 1-(3-Pyrrolidinopropyl)homopiperazine REF: 10-F008916CAS: 199475-39-3 | 97.0% | To inquire | Tue 18 Feb 25 |
 | 1-(3-Pyrrolidinepropyl)homopiperazine REF: 3D-ZHA47539CAS: 199475-39-3 | Min. 95% | - - - | Discontinued product |
![1H-1,4-Diazepine, hexahydro-1-[3-(1-pyrrolidinyl)propyl]-](https://static.cymitquimica.com/products/IN/thumb/DA002C4Q.jpg)
1H-1,4-Diazepine, hexahydro-1-[3-(1-pyrrolidinyl)propyl]-
CAS:199475-39-3
Formula:
C12H25N3
Molecular weight:
211.3470
Ref: IN-DA002C4Q
| Undefined size | To inquire |
Estimated delivery in United States, on Friday 7 Feb 2025
![1-[3-(Pyrrolidin-1-yl)prop-1-yl]homopiperazine](https://static.cymitquimica.com/products/54/thumb/OR3475.jpg)
1-[3-(Pyrrolidin-1-yl)prop-1-yl]homopiperazine
CAS:199475-39-3
Formula:
C12H25N3
Purity:
97%
Color and Shape:
colourless to light yellow liquid/ oil
Molecular weight:
211.35g/mol
Ref: 54-OR3475
| 1g | 54.00 € |
Estimated delivery in United States, on Friday 14 Feb 2025
1-(3-Pyrrolidinopropyl)homopiperazine
CAS:199475-39-3
Purity:
97.0%
Color and Shape:
Solid
Molecular weight:
211.35299682617188
Ref: 10-F008916
| 1g | To inquire | ||
| 250mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
1-(3-Pyrrolidinepropyl)homopiperazine
CAS:199475-39-3
Versatile small molecule scaffold
Formula:
C12H25N3
Purity:
Min. 95%
Molecular weight:
211.35 g/mol
Ref: 3D-ZHA47539
| 1g | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information | |
| 100mg | Discontinued | Request information | |
| 250mg | Discontinued | Request information |
